Health CanadaGeneral Alert
Sublinox (zolpidem tartrate) - New Dosage Recommendations to Minimize Risk of Ne...
Published: January 3, 2014Recall ID: 50959Category: generalCountry: Canada
Reason for Recall / Hazard
Dosage
Product Description & Identification
Sublinox (zolpidem tartrate) - New Dosage Recommendations to Minimize Risk of Next-Day Impairment in Both Women and Men - For the Public
Additional Source Details
| Field | Value |
|---|---|
| N I D | 50959 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/sublinox-zolpidem-tartrate-new-dosage-recommendations-minimize-risk-next-day-0 |
| Issue | Dosage |
| Title | Sublinox (zolpidem tartrate) - New Dosage Recommendations to Minimize Risk of Next-Day Impairment in Both Women and Men - For the Public |
| Archived | 1 |
| Category | Drugs |
| Last updated | 2014-01-03 |
| Organization | Marketed health products |